Tim Pelura is an accomplished executive in the life sciences sector with extensive experience in leadership roles, including current positions as Executive Chairman at Haima Therapeutics and Respana Therapeutics Inc., and as President & CEO of BioEntrepid, Inc. Pelura has a proven track record in advancing biopharmaceutical innovations, evident from previous roles such as CEO at OptiKira, President & CEO at Surpass, Inc., and Immunome, Inc. Additionally, Pelura has contributed to organizations like BioStrategy Partners, Inc. and The Medical Alley Association as a board member, demonstrating commitment to the development and commercialization of scientific research. With a strong academic background in lipid chemistry, chemistry, and biology from Rutgers University, Pelura's expertise spans various aspects of drug development and commercialization in the biotechnology field.